Why do eosinophils increase

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 8, 2026

Quick Answer: Eosinophils increase primarily in response to parasitic infections, allergic reactions, and certain autoimmune diseases. For example, in allergic asthma, eosinophil counts can rise from normal levels of 0-500 cells/μL to over 1,500 cells/μL. Specific triggers include helminth infections like hookworms, which can elevate eosinophils by 10-30% of total white blood cells. This increase typically occurs within 24-48 hours after exposure to allergens or parasites.

Key Facts

Normal eosinophil count is 0-500 cells per microliter of blood
Eosinophilia is defined as >500 eosinophils/μL in peripheral blood
Parasitic infections can increase eosinophils to 10-30% of total WBCs
Allergic asthma often shows eosinophil counts >1,500 cells/μL
Eosinophil levels typically rise within 24-48 hours after exposure

Overview

Eosinophils are a type of white blood cell that play a crucial role in the immune system's response to parasites and allergic reactions. First identified by Paul Ehrlich in 1879 through his staining techniques, eosinophils derive their name from their affinity for eosin dye, which gives them a distinctive pink appearance under microscopy. These cells typically constitute 1-3% of circulating white blood cells in healthy individuals, with normal counts ranging from 0 to 500 cells per microliter of blood. Historically, eosinophils were primarily associated with parasitic infections, but research since the 1970s has revealed their involvement in various inflammatory conditions, including asthma, eczema, and eosinophilic gastrointestinal disorders. The discovery of interleukin-5 (IL-5) in the 1980s as a key regulator of eosinophil production and activation marked a significant advancement in understanding these cells' biology.

How It Works

Eosinophil increase occurs through a coordinated process involving bone marrow production, release into circulation, and tissue migration. When the immune system detects parasites, allergens, or certain inflammatory signals, T-helper type 2 (Th2) cells release cytokines, particularly interleukin-5 (IL-5), which stimulates eosinophil production in bone marrow. This process typically begins within hours of exposure, with mature eosinophils entering the bloodstream within 24-48 hours. Once in circulation, eosinophils migrate to affected tissues guided by chemokines like eotaxin, where they release cytotoxic granules containing major basic protein, eosinophil peroxidase, and eosinophil cationic protein. These substances help combat parasites but can also damage host tissues in allergic conditions. In parasitic infections, eosinophils directly attack helminths through degranulation and oxidative bursts. In allergic reactions, they contribute to inflammation by releasing leukotrienes and other mediators that cause bronchoconstriction and tissue swelling.

Why It Matters

Understanding eosinophil increases has significant clinical implications for diagnosis and treatment. Elevated eosinophil counts serve as important biomarkers for conditions like asthma, where they correlate with disease severity and predict response to corticosteroid therapy. In parasitic infections, eosinophilia helps diagnose conditions that might otherwise go undetected in asymptomatic carriers. The development of targeted therapies like mepolizumab and benralizumab, which specifically inhibit IL-5 signaling, has revolutionized treatment for severe eosinophilic asthma, reducing exacerbations by 50-70% in clinical trials. Monitoring eosinophil levels also helps manage drug reactions, autoimmune diseases, and certain cancers like Hodgkin lymphoma, where eosinophilia can indicate disease activity. Furthermore, research into eosinophil biology continues to uncover new therapeutic targets for inflammatory diseases affecting millions worldwide.